Three-Year Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting
Crossref DOI link: https://doi.org/10.1007/s40123-018-0139-5
Published Online: 2018-07-07
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Eleftheriadou, Maria
Gemenetzi, Maria
Lukic, Marko
Sivaprasad, Sobha
Hykin, Philip G.
Hamilton, Robin D.
Rajendram, Ranjan
Tufail, Adnan
Patel, Praveen J.
Article History
Received: 4 June 2018
First Online: 7 July 2018